Dirk A. Heerding

3.1k total citations
23 papers, 870 citations indexed

About

Dirk A. Heerding is a scholar working on Molecular Biology, Organic Chemistry and Epidemiology. According to data from OpenAlex, Dirk A. Heerding has authored 23 papers receiving a total of 870 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Organic Chemistry and 2 papers in Epidemiology. Recurrent topics in Dirk A. Heerding's work include Click Chemistry and Applications (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Ubiquitin and proteasome pathways (4 papers). Dirk A. Heerding is often cited by papers focused on Click Chemistry and Applications (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and Ubiquitin and proteasome pathways (4 papers). Dirk A. Heerding collaborates with scholars based in United States, United Kingdom and India. Dirk A. Heerding's co-authors include Elisabeth A. Minthorn, Dennis T. Takata, William F. Huffman, Stephen Rittenhouse, Rakesh Kumar, Mark A. Seefeld, William H. Miller, Meagan B. Rouse, Jesús R. Medina and Jeffrey M. Axten and has published in prestigious journals such as Journal of the American Chemical Society, PLoS ONE and Journal of Molecular Biology.

In The Last Decade

Dirk A. Heerding

23 papers receiving 844 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk A. Heerding United States 15 484 358 171 110 75 23 870
Mei-Chu Lo United States 11 750 1.5× 117 0.3× 68 0.4× 54 0.5× 132 1.8× 19 957
Eunice EunKyeong Kim South Korea 23 1.1k 2.2× 147 0.4× 201 1.2× 130 1.2× 281 3.7× 84 1.5k
Stephan K. Grant United States 17 578 1.2× 247 0.7× 76 0.4× 78 0.7× 269 3.6× 26 1.0k
Claire A. Minshull United Kingdom 12 488 1.0× 340 0.9× 60 0.4× 30 0.3× 264 3.5× 12 961
Matthew J. LaMarche United States 20 583 1.2× 421 1.2× 101 0.6× 65 0.6× 343 4.6× 45 1.1k
Roderick J. Sorenson United States 19 647 1.3× 632 1.8× 34 0.2× 52 0.5× 103 1.4× 35 1.4k
Pengfei Fang China 19 821 1.7× 179 0.5× 58 0.3× 54 0.5× 103 1.4× 59 1.1k
Timothy L. Foley United States 17 591 1.2× 233 0.7× 41 0.2× 34 0.3× 57 0.8× 27 807
Girija Krishnamurthy United States 18 432 0.9× 355 1.0× 30 0.2× 85 0.8× 68 0.9× 30 867
Louis Plamondon United States 15 942 1.9× 429 1.2× 128 0.7× 142 1.3× 357 4.8× 27 1.4k

Countries citing papers authored by Dirk A. Heerding

Since Specialization
Citations

This map shows the geographic impact of Dirk A. Heerding's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk A. Heerding with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk A. Heerding more than expected).

Fields of papers citing papers by Dirk A. Heerding

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk A. Heerding. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk A. Heerding. The network helps show where Dirk A. Heerding may publish in the future.

Co-authorship network of co-authors of Dirk A. Heerding

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk A. Heerding. A scholar is included among the top collaborators of Dirk A. Heerding based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk A. Heerding. Dirk A. Heerding is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Marco, Christina N. Di, Lamont R. Terrell, Robert A. Sanchez, et al.. (2023). Design and synthesis of aminopyridine containing biaryls reducing c-MYC protein levels in cells. Bioorganic & Medicinal Chemistry Letters. 92. 129385–129385. 1 indexed citations
2.
Palanisamy, Gopinath S., Venkateshappa Chandregowda, Brian R. Hearn, et al.. (2023). Abstract A044: The discovery of potent KAT6 inhibitors that demonstrate anti-tumor activity in preclinical models of ER+ breast cancer. Molecular Cancer Therapeutics. 22(12_Supplement). A044–A044. 1 indexed citations
3.
Horton, J.R., Kristen Wong, Ren Ren, et al.. (2022). Structural characterization of dicyanopyridine containing DNMT1-selective, non-nucleoside inhibitors. Structure. 30(6). 793–802.e5. 19 indexed citations
4.
Horton, J.R., Kristen Wong, Ren Ren, et al.. (2022). Structural Characterization of Dicyanopyridine Containing DNMT1-Selective, Non-Nucleoside Inhibitors. SSRN Electronic Journal. 1 indexed citations
5.
Zhang, Wei, Taras Makhnevych, Kelly Federowicz, et al.. (2017). Generation and Validation of Intracellular Ubiquitin Variant Inhibitors for USP7 and USP10. Journal of Molecular Biology. 429(22). 3546–3560. 43 indexed citations
6.
Concha, N.O., Angela Smallwood, William G. Bonnette, et al.. (2015). Long-Range Inhibitor-Induced Conformational Regulation of Human IRE1α Endoribonuclease Activity. Molecular Pharmacology. 88(6). 1011–1023. 42 indexed citations
7.
Dumble, Melissa, Ming‐Chih Crouthamel, Shuyun Zhang, et al.. (2014). Discovery of Novel AKT Inhibitors with Enhanced Anti-Tumor Effects in Combination with the MEK Inhibitor. PLoS ONE. 9(6). e100880–e100880. 116 indexed citations
8.
Rouse, Meagan B., Mark A. Seefeld, Jack D. Leber, et al.. (2009). Aminofurazans as potent inhibitors of AKT kinase. Bioorganic & Medicinal Chemistry Letters. 19(5). 1508–1511. 33 indexed citations
9.
Lin, Hong, Dennis S. Yamashita, Jin Zeng, et al.. (2009). 2,3,5-Trisubstituted pyridines as selective AKT inhibitors—Part I: Substitution at 2-position of the core pyridine for ROCK1 selectivity. Bioorganic & Medicinal Chemistry Letters. 20(2). 673–678. 11 indexed citations
10.
Seefeld, Mark A., Meagan B. Rouse, Jizhou Wang, et al.. (2009). Discovery of 5-pyrrolopyridinyl-2-thiophenecarboxamides as potent AKT kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 19(8). 2244–2248. 21 indexed citations
11.
Lin, Hong, Dennis S. Yamashita, Jin Zeng, et al.. (2009). 2,3,5-Trisubstituted pyridines as selective AKT inhibitors. Part II: Improved drug-like properties and kinase selectivity from azaindazoles. Bioorganic & Medicinal Chemistry Letters. 20(2). 679–683. 8 indexed citations
12.
Safonov, Igor G., Dirk A. Heerding, Richard M. Keenan, et al.. (2006). New benzimidazoles as thrombopoietin receptor agonists. Bioorganic & Medicinal Chemistry Letters. 16(5). 1212–1216. 37 indexed citations
13.
Heerding, Dirk A., Tammy J. Clark, David Holmes, et al.. (2003). New Benzylidenethiazolidinediones as Antibacterial Agents. Bioorganic & Medicinal Chemistry Letters. 13(21). 3771–3773. 47 indexed citations
14.
Miller, William H., Mark A. Seefeld, Kenneth A. Newlander, et al.. (2002). Discovery of Aminopyridine-Based Inhibitors of Bacterial Enoyl-ACP Reductase (FabI). Journal of Medicinal Chemistry. 45(15). 3246–3256. 90 indexed citations
15.
Heerding, Dirk A., George Chan, Walter E. DeWolf, et al.. (2001). 1,4-Disubstituted imidazoles are potential antibacterial agents functioning as inhibitors of enoyl acyl carrier protein reductase (FabI). Bioorganic & Medicinal Chemistry Letters. 11(16). 2061–2065. 110 indexed citations
16.
Heerding, Dirk A., Joelle L. Burgess, James F. Callahan, et al.. (2000). Novel peptidomimetic hematoregulatory compounds. Bioorganic & Medicinal Chemistry Letters. 10(6). 531–534. 2 indexed citations
17.
Bhatnagar, Pradip K., James F. Callahan, Dirk A. Heerding, et al.. (1996). Development of a Pharmacophore Model for a Novel Hematoregulatory Peptide. Journal of the American Chemical Society. 118(50). 12862–12863. 9 indexed citations
18.
Heerding, Dirk A., et al.. (1996). Stereoselective synthesis of (2R)-6-Benzyloxycarbonylamino-2-tert-butoxycarbonylaminohex-4-ynoic Acid. Tetrahedron Asymmetry. 7(1). 237–242. 2 indexed citations
19.
Heerding, Dirk A., Chang Yong Hong, Noriyuki Kado, Gary C. Look, & Larry E. Overman. (1993). Simple method for controlling stereoselection in Mannich cyclization reactions of aldehydes. The Journal of Organic Chemistry. 58(25). 6947–6948. 19 indexed citations
20.
Deardorff, Donald R., Soroosh Shambayati, David C. Myles, & Dirk A. Heerding. (1988). Studies on the synthesis of (-)-neplanocin A. Homochiral preparation of a key cyclopentanoid intermediate. The Journal of Organic Chemistry. 53(15). 3614–3615. 27 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mei-Chu Lo Breakdown of academic impact, for papers by Eunice EunKyeong Kim Breakdown of academic impact, for papers by Stephan K. Grant Breakdown of academic impact, for papers by Claire A. Minshull Breakdown of academic impact, for papers by Matthew J. LaMarche Breakdown of academic impact, for papers by Roderick J. Sorenson Breakdown of academic impact, for papers by Pengfei Fang Breakdown of academic impact, for papers by Timothy L. Foley Breakdown of academic impact, for papers by Girija Krishnamurthy Breakdown of academic impact, for papers by Louis Plamondon
Rankless by CCL
2026